Maria Mudryj
Affiliations: | University of California, Davis, Davis, CA |
Area:
Molecular Biology, GeneticsGoogle:
"Maria Mudryj"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Katleba KD, Ghosh PM, Mudryj M. (2023) Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development. Biomedicines. 11 |
| Jathal MK, Siddiqui S, Vasilatis DM, et al. (2023) Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. The Journal of Biological Chemistry. 104973 |
| Katleba KD, Tsamouri MM, Jathal M, et al. (2023) Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Scientific Reports. 13: 1762 |
| Katleba K, Lombard AP, Tsamouri MM, et al. (2021) Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis. Cancer Letters |
| Kiss Z, Mudryj M, Ghosh PM. (2020) Non-circadian aspects of BHLHE40 cellular function in cancer. Genes & Cancer. 11: 1-19 |
| Siddiqui S, Libertini SJ, Lucas CA, et al. (2020) The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells. Cancer Letters |
| Baek HB, Lombard AP, Libertini SJ, et al. (2018) XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. Oncotarget. 9: 34567-34581 |
| D'Abronzo LS, Bose S, Crapuchettes ME, et al. (2017) The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene |
| Lombard AP, Mudryj M. (2015) The emerging role of the androgen receptor in bladder cancer. Endocrine-Related Cancer. 22: R265-77 |
| Lombard AP, Lim RM, Nakagawa RM, et al. (2015) Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncology Reports. 34: 1526-32 |